Hepatitis C virus infection and cardiomyopathies

MeSH terms

• Animals
• Antiviral Agents / therapeutic use
• Atrial Natriuretic Factor / biosynthesis
• Atrial Natriuretic Factor / genetics
• Cardiomyopathies / drug therapy
• Cardiomyopathies / epidemiology
• Cardiomyopathies / etiology*
• Cardiomyopathies / immunology
• Cardiomyopathies / virology
• Gene Expression Regulation, Viral
• HLA-D Antigens / immunology
• Heart / virology
• Heart Failure / epidemiology
• Heart Failure / etiology
• Heart Failure / virology
• Hepacivirus / genetics
• Hepacivirus / isolation & purification
• Hepacivirus / pathogenicity
• Hepacivirus / physiology*
• Hepatitis C / complications*
• Hepatitis C / epidemiology
• Hepatitis C Antibodies / blood
• Humans
• Interferons / therapeutic use
• Mice
• Mice, Transgenic
• Myocarditis / complications*
• Myocarditis / immunology
• Myocarditis / virology
• Myocardium / chemistry
• Myocardium / pathology
• NF-kappa B / analysis
• Natriuretic Peptide, Brain / biosynthesis
• Natriuretic Peptide, Brain / genetics
• Paraffin Embedding
• Phenotype
• Prevalence
• RNA, Viral / analysis
• Species Specificity
• Transcription Factor AP-1 / metabolism
• Viral Core Proteins / genetics
• Viral Core Proteins / physiology